Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Synlife
AddedFeb 18, 2024
UpdatedJun 18, 2026
Synlife

Synlife

Seed

Synlife: Innovating therapeutic and diagnostic solutions through engineered synthetic cells for medical research.

HQ
Cambridge, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize medical research, Synlife focuses on developing innovative therapeutic and diagnostic platforms through the bottom-up engineering of synthetic cells. The company builds synthetic minimal cells that contain a biochemical mix of proteins capable of transcribing and translating genes, along with a DNA program. This technology enables the detection of low-abundance molecular markers and cells, offering significant advancements in medical research and diagnostics.

Synlife's notable achievements include the successful encapsulation of enzyme pathways, paving the way for novel therapeutic solutions. The company has garnered attention from leading figures in biotechnology and has attracted investment from prominent venture capital firms specializing in life sciences. Synlife's impact on the medical research community is profound, providing new tools and methodologies for detecting and treating diseases at a molecular level.

Synlife - Similar Companies

Think Bioscience logo

Think Bioscience

Synthex logo

Synthex

Syncell logo

Syncell

syncell.com

Synova Life Sciences logo

Synova Life Sciences

synovalife.com

AI Proteins logo

AI Proteins

aiproteinstx.com

Antheia logo

Antheia

antheia.bio

Spheringenics logo

Spheringenics

LifeX logo

LifeX

lifex-labs.com

Satellite Bio logo

Satellite Bio

satellite.bio

Synonym logo

Synonym

synonym.bio

LifeSprout logo

LifeSprout

lifesproutbio.com

Senti Biosciences logo

Senti Biosciences

sentibio.com

Synbody Biotechnology logo

Synbody Biotechnology

Pearl Bio logo

Pearl Bio

pearlbio.com

Synspira logo

Synspira

Synlife - Quick Facts

Who are Synlife's competitors?

Companies similar to Synlife include Think Bioscience, Synthex, Syncell and Synova Life Sciences.

When was Synlife founded?

Synlife was founded in 2017.

Where is Synlife's headquarters located?

Synlife's headquarters is located in Cambridge, MA, US.

When was Synlife's last funding round?

Synlife's most recent funding round was for $700k (USD) in July 2018.

How much has Synlife raised to-date?

As of Jul 27, 2018, Synlife has raised a total of $700k (USD).

How many employees does Synlife have?

Synlife has 2 employees as of Feb 5, 2024.

Synlife - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Medical Research
Tags
  • Consulting
  • Platform
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified